Privia Health Group, Inc. (NASDAQ:PRVA) Shares Bought by Franklin Resources Inc.

Franklin Resources Inc. grew its position in Privia Health Group, Inc. (NASDAQ:PRVA) by 2.2% in the third quarter, HoldingsChannel reports. The institutional investor owned 1,300,240 shares of the company’s stock after acquiring an additional 28,480 shares during the period. Franklin Resources Inc.’s holdings in Privia Health Group were worth $23,092,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently modified their holdings of the company. Sequoia Financial Advisors LLC boosted its holdings in Privia Health Group by 2.3% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 26,246 shares of the company’s stock valued at $478,000 after acquiring an additional 583 shares during the period. Benjamin F. Edwards & Company Inc. boosted its stake in shares of Privia Health Group by 8.5% in the second quarter. Benjamin F. Edwards & Company Inc. now owns 7,695 shares of the company’s stock valued at $134,000 after purchasing an additional 605 shares during the period. Arizona State Retirement System boosted its stake in shares of Privia Health Group by 2.4% in the second quarter. Arizona State Retirement System now owns 26,574 shares of the company’s stock valued at $462,000 after purchasing an additional 617 shares during the period. Signaturefd LLC grew its holdings in shares of Privia Health Group by 46.3% in the second quarter. Signaturefd LLC now owns 1,978 shares of the company’s stock valued at $34,000 after purchasing an additional 626 shares in the last quarter. Finally, Parkside Financial Bank & Trust increased its stake in Privia Health Group by 9.7% during the 2nd quarter. Parkside Financial Bank & Trust now owns 8,684 shares of the company’s stock worth $151,000 after buying an additional 771 shares during the period. Hedge funds and other institutional investors own 94.48% of the company’s stock.

Analyst Ratings Changes

Several brokerages have commented on PRVA. Robert W. Baird raised their price target on shares of Privia Health Group from $23.00 to $24.00 and gave the company an “outperform” rating in a research report on Monday, August 26th. Barclays lifted their target price on Privia Health Group from $19.00 to $21.00 and gave the company an “equal weight” rating in a report on Friday, November 8th. Truist Financial upped their price target on Privia Health Group from $24.00 to $27.00 and gave the stock a “buy” rating in a report on Friday, November 8th. JPMorgan Chase & Co. lifted their price objective on Privia Health Group from $27.00 to $28.00 and gave the company an “overweight” rating in a research note on Friday, November 29th. Finally, Macquarie began coverage on shares of Privia Health Group in a research note on Monday. They set an “outperform” rating and a $25.00 target price on the stock. Two analysts have rated the stock with a hold rating, twelve have assigned a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus price target of $24.80.

Privia Health Group Stock Performance

PRVA opened at $20.13 on Friday. Privia Health Group, Inc. has a one year low of $15.92 and a one year high of $24.30. The stock has a market capitalization of $2.42 billion, a P/E ratio of 201.32, a price-to-earnings-growth ratio of 5.45 and a beta of 0.83. The business’s 50-day simple moving average is $20.25 and its 200-day simple moving average is $19.11.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.